Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma

Autor: Qing Zhu, Yiping Dong, Congya Zhou, Xia Ying, Mengjiao Cai, Chenchen He, Xin Sui, Wenli Gou, Chengxian Ma, Suxia Han, Xiao Sun, Yuanyuan Zhang, Clifford W. Mason
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Pathology
medicine.medical_specialty
Cirrhosis
Carcinoma
Hepatocellular

autoantibodies
Enzyme-Linked Immunosorbent Assay
Gastroenterology
Metastasis
03 medical and health sciences
0302 clinical medicine
heptocellular carcinoma (HCC)
proteomics
Obstetrics and gynaecology
Internal medicine
Cell Line
Tumor

medicine
Carcinoma
Biomarkers
Tumor

Humans
Neoplasm Metastasis
Fluorescent Antibody Technique
Indirect

Endoplasmic Reticulum Chaperone BiP
Heat-Shock Proteins
business.industry
Liver Neoplasms
Autoantibody
Hep G2 Cells
medicine.disease
HCT116 Cells
Recurrent Hepatocellular Carcinoma
digestive system diseases
030104 developmental biology
Oncology
030220 oncology & carcinogenesis
Case-Control Studies
tumor associated antigens (TAA)
MCF-7 Cells
Biomarker (medicine)
Immunohistochemistry
biomarker
business
Research Paper
HeLa Cells
Zdroj: Oncotarget
ISSN: 1949-2553
Popis: // Xia Ying 1, 2 , Su-xia Han 3 , Chen-chen He 3 , Cong-ya Zhou 1 , Yi-ping Dong 3 , Meng-jiao Cai 1 , Xin Sui 3 , Cheng-xian Ma 1 , Xiao Sun 3 , Yuan-yuan Zhang 1 , Wen-li Gou 4 , Clifford Mason 5 , Qing Zhu 1 1 Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University Medical College, Xi’an, Shannxi, P.R. China 2 Department of Gynecological Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China 3 Department of Oncology, The First Affiliated Hospital of Xi’an Jiaotong University Medical College, Xi’an, Shannxi, P.R. China 4 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi’an Jiaotong University Medical College, Xi’an, Shannxi, P.R. China 5 Department of Obstetrics and Gynecology, University of Kansas School of Medicine, Kansas City, Kansas, USA Correspondence to: Qing Zhu, email: newzhuqing1972@yahoo.com Keywords: heptocellular carcinoma (HCC), tumor associated antigens (TAA), proteomics, autoantibodies, biomarker Received: June 03, 2016 Accepted: December 05, 2016 Published: February 08, 2017 ABSTRACT Purpose: To identify Heptocellular carcinoma (HCC) associated antigens by proteomics, and validate whether autoantibodies against tumor-associated antigens (TAAs) could be used for diagnosis and conditional monitoring. Results: The 78 kDa glucose regulated protein (GRP78) was selected as a candidate TAA. The titers of autoantibodies against 78 kDa glucose regulated protein (GRP78) from patients with HCC, liver cirrhosis (LC), and chronic hepatitis (CH) were significantly higher than that from normal controls ( P
Databáze: OpenAIRE